Table 2.
The Ablation Procedure and Complications.
| Total procedure time (groin puncture to catheter extraction), min |
| Left atrial dwell time, min |
| Total fluoroscopy time, min |
| Total absorbed dose, mGy |
| PVI success, n (%) |
| For cryoablation |
| Total freeze cycles, n |
| Freeze cycles per vein, n |
| Time to isolation per vein, s |
| Additional freeze cycles, n |
| Total freeze time, s |
| Freeze time per vein, s |
| Minimum balloon temperature, ℃ |
| The need for touch up ablation, n (%) |
| For radiofrequency ablation |
| Type of ablation catheter |
| Output and duration of radiofrequency application |
| Total radiofrequency application time, s |
| Other adjunctive ablation, n (%) |
| Use and type of 3D mapping system, n (%) |
| Use of general anesthesia, n (%) |
| Use of esophageal temperature probe, n (%) |
| Quantity of contrast media, ml |
| Number of case experiences per operator, n |
| Complications, n (%) |
| Pericardial effusion requiring drainage |
| Pericardial effusion not requiring drainage |
| Transient ischemic attack |
| Cerebral infarction |
| Other thromboembolisms |
| Transient phrenic nerve paralysis |
| Prolonged phrenic nerve paralysis |
| Severe pulmonary vein stenosis (>70% reduction in pulmonary vein diameter) |
| Hematoma at the puncture site |
| Pseudoaneurysm at the puncture site |
| Gastric hypomotility |
| Death |
| Others |
| Discharge prescription, n (%) |
| Oral anticoagulant |
| Antiarrhythmic drugs |
| Disopyramide |
| Cibenzoline |
| Pirmenol |
| Procainamide |
| Quinidine |
| Aprindine |
| Pilsicainide |
| Flecainide |
| Propafenone |
| Amiodarone |
| Sotalol |
| Bepridil |
| Others |
| Antiplatelet drug |
| Beta-blocker |
| Angiotensin converting enzyme inhibitor/Angiotensin II receptor blocker |
| Angiotensin receptor-neprilysin inhibitor |
| Ivabradine |
| Digitalis |
| Calcium channel blocker |
| Loop diuretic |
| Statin |